United States Biotechnology & Medical Research

MetaVia Inc (MTVA)

Track

Track

Ticker: MTVA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MetaVia Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Woodworth Marshall H Chief Financial Officer Officer
Transaction date
Purchase
Price
406.93
Quantity 47,862 -3.9%
Value US$601,217
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Purchase
Price
480.47
Quantity 93,868 +1.8%
Value US$1,074,857
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Sale
Price
373.35
Quantity 84,363 +13.4%
Value US$449,526
2.1
DONG-A ST CO., LTD Large shareholder
Transaction date
Purchase
Price
3.13
Quantity 2,544,530 +90.8%
Value US$7,964,379
Reno Seth Chief Commercial Officer Officer
Transaction date
Purchase
Price
7.00
Quantity 14,286 +357.1%
Value US$100,002
Gullans Steven R. Ph.D. Interim President & CEO Executive Director
Transaction date
Purchase
Price
7.00
Quantity 71,429 +8.3%
Value US$500,003
Hawryluk P. Kent
Transaction date
Purchase
Price
9.47
Quantity 25,000 +43.9%
Value US$236,750
Gullans Steven R. Ph.D.
Transaction date
Purchase
Price
9.47
Quantity 52,798 +6.6%
Value US$499,997
LICHTINGER PEDRO
Transaction date
Purchase
Price
9.47
Quantity 10,559 +21.4%
Value US$99,994
SASSINE ANDY
Transaction date
Purchase
Price
9.47
Quantity 21,119 +18.3%
Value US$199,997
Hawryluk P. Kent Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 25,000 +78.4%
Value US$250,000
Gullans Steven R. Ph.D. Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 500,000 +163.4%
Value US$5,000,000
Sooch Mina President & CEO Executive Director
Transaction date
Purchase
Price
10.00
Quantity 52,500 +8.2%
Value US$525,000
MATHIESEN JEFFREY S Chief Financial Officer Officer
Transaction date
Purchase
Price
10.00
Quantity 4,000 +101.9%
Value US$40,000
Bisgaier Charles PhD Chair & Chief Scientific Off. Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 51,750 +4.3%
Value US$517,500
LICHTINGER PEDRO Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 10,000 +25.5%
Value US$100,000
KOUSKY KENNETH W Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 1,000 +inf%
Value US$10,000
Reno Seth Chief Commercial Officer Officer
Transaction date
Purchase
Price
10.00
Quantity 4,000 +inf%
Value US$40,000
Lowenschuss David Chief Legal Off. & Secretary Officer
Transaction date
Purchase
Price
10.00
Quantity 11,120 +1.4%
Value US$111,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-04 2025-06-04 B Purchase
1.6
Woodworth Marshall H

Chief Financial Officer

Officer
47,862 -3.9%
406.93
US$601,217 		47,862 -3.9% 406.93 US$601,217
2025-05-20 2025-05-08 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
93,868 +1.8%
480.47
US$1,074,857 		93,868 +1.8% 480.47 US$1,074,857
2024-09-20 2024-09-12 S Sale
2.1
DONG-A ST CO., LTD
Large shareholder
84,363 +13.4%
373.35
US$449,526 		84,363 +13.4% 373.35 US$449,526
2024-06-25 2024-06-23 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
2,544,530 +90.8%
3.13
US$7,964,379 		2,544,530 +90.8% 3.13 US$7,964,379
2018-02-12 2018-02-08 B Purchase Reno Seth

Chief Commercial Officer

Officer
14,286 +357.1%
7.00
US$100,002 		14,286 +357.1% 7.00 US$100,002
2018-02-12 2018-02-08 B Purchase Gullans Steven R. Ph.D.

Interim President & CEO

Executive Director
71,429 +8.3%
7.00
US$500,003 		71,429 +8.3% 7.00 US$500,003
2017-03-14 2017-03-10 B Purchase Hawryluk P. Kent
25,000 +43.9%
9.47
US$236,750 		25,000 +43.9% 9.47 US$236,750
2017-03-14 2017-03-10 B Purchase Gullans Steven R. Ph.D.
52,798 +6.6%
9.47
US$499,997 		52,798 +6.6% 9.47 US$499,997
2017-03-14 2017-03-10 B Purchase LICHTINGER PEDRO
10,559 +21.4%
9.47
US$99,994 		10,559 +21.4% 9.47 US$99,994
2017-03-14 2017-03-10 B Purchase SASSINE ANDY
21,119 +18.3%
9.47
US$199,997 		21,119 +18.3% 9.47 US$199,997
2016-08-12 2016-08-10 B Purchase Hawryluk P. Kent Non-Executive Director
25,000 +78.4%
10.00
US$250,000 		25,000 +78.4% 10.00 US$250,000
2016-08-12 2016-08-10 B Purchase Gullans Steven R. Ph.D. Non-Executive Director
500,000 +163.4%
10.00
US$5,000,000 		500,000 +163.4% 10.00 US$5,000,000
2016-08-12 2016-08-10 B Purchase Sooch Mina

President & CEO

Executive Director
52,500 +8.2%
10.00
US$525,000 		52,500 +8.2% 10.00 US$525,000
2016-08-12 2016-08-10 B Purchase MATHIESEN JEFFREY S

Chief Financial Officer

Officer
4,000 +101.9%
10.00
US$40,000 		4,000 +101.9% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Bisgaier Charles PhD

Chair & Chief Scientific Off.

Executive Director Large shareholder
51,750 +4.3%
10.00
US$517,500 		51,750 +4.3% 10.00 US$517,500
2016-08-12 2016-08-10 B Purchase LICHTINGER PEDRO Non-Executive Director
10,000 +25.5%
10.00
US$100,000 		10,000 +25.5% 10.00 US$100,000
2016-08-12 2016-08-10 B Purchase KOUSKY KENNETH W Non-Executive Director
1,000 +inf%
10.00
US$10,000 		1,000 +inf% 10.00 US$10,000
2016-08-12 2016-08-10 B Purchase Reno Seth

Chief Commercial Officer

Officer
4,000 +inf%
10.00
US$40,000 		4,000 +inf% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Lowenschuss David

Chief Legal Off. & Secretary

Officer
11,120 +1.4%
10.00
US$111,200 		11,120 +1.4% 10.00 US$111,200
Explore more

More insider trading research around MetaVia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America